{"id":2894,"date":"2019-09-18T06:00:00","date_gmt":"2019-09-18T06:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xps-sald-till-kina\/"},"modified":"2019-09-18T06:00:00","modified_gmt":"2019-09-18T06:00:00","slug":"xps-sald-till-kina","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/","title":{"rendered":"XPS\u2122 s\u00e5ld till Kina"},"content":{"rendered":"
XVIVO Perfusion har s\u00e5lt en XPS\u2122 till Kinas n\u00e4st st\u00f6rsta lungtransplantationsklinik, CHINA\u2013JAPAN FRIENDSHIP HOSPITAL, i Peking. P\u00e5 kliniken ska forskning kring EVLP (Ex Vivo Lung Perfusion) startas.<\/strong><\/div>\n

Kina \u00e4r f\u00f6r n\u00e4rvarande v\u00e4rldens snabbast v\u00e4xande lungtransplantationsmarknad med en \u00f6kning om 35% i antal lungtransplantationer 2018 (403 genomf\u00f6rda lungtransplantationer). P\u00e5 grund av det \u00f6kade behovet av lungtransplantation har antalet kliniker som \u00e4r godk\u00e4nda f\u00f6r att genomf\u00f6ra lungtransplantationer \u00f6kat fr\u00e5n 20 kliniker 2016 till 37 kliniker 2018. <\/span><\/p>\n

Professor JINGYU CHEN, som idag har ansvar f\u00f6r lungtransplantationsprogrammet vid CHINA-JAPAN FRIENDSHIP HOSPITAL i Peking, kommer ocks\u00e5 att leda EVLP-programmet. Det \u00e4r den n\u00e4st st\u00f6rsta kliniken f\u00f6r lungtransplantation i Kina och syftet med programmet \u00e4r att utv\u00e4rdera effekterna av EVLP vid lungtransplantationer. Forskningssyftet \u00e4r att utv\u00e4rdera EVLP i klinisk milj\u00f6 i Kina, vilket medf\u00f6r att kinesisk data kan adderas till befintlig EVLP-data fr\u00e5n Nordamerika och Europa. XVIVO Perfusion har initierat en registreringsprocess f\u00f6r XPS\u2122 hos NMPA, Kinas regulatoriska myndighet. I samarbete med XVIVO Perfusions distribut\u00f6r i Kina (Shanghai Genext Medial Technology Co., Ltd) \u00e4r bolagets plan att ge forskningsst\u00f6d till lungtransplantationskliniken p\u00e5 CHINA-JAPAN FRIENDSHIP HOSPITAL.<\/span><\/p>\n

\u201dVi \u00e4r v\u00e4ldigt glada \u00f6ver att ha levererat en XPS till ytterligare en kinesisk klinik. Med tanke p\u00e5 befolkningens storlek, samt den snabba \u00f6kningen av levnadsstandard och standard inom h\u00e4lso- och sjukv\u00e5rd, f\u00f6rv\u00e4ntas Kina bli en viktig marknad f\u00f6r XVIVO i en n\u00e4ra framtid\u201d, s\u00e4ger Magnus Nilsson, VD f\u00f6r XVIVO Perfusion.<\/span><\/p>\n

G\u00f6teborg den 18 september, 2019
Magnus Nilsson, VD<\/span><\/p>\n

XVIVO Perfusion AB (publ)<\/span><\/p>\n

\n

F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n

Christoffer Rosenblad, CFO, +46 735 192 159, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, VD, +46 31 788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/p>\n

F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/p>\n

Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande klockan 08.00 den 18 september 2019.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion har s\u00e5lt en XPS\u2122 till Kinas n\u00e4st st\u00f6rsta lungtransplantationsklinik, CHINA\u2013JAPAN FRIENDSHIP HOSPITAL, i Peking. P\u00e5 kliniken ska forskning…<\/p>\n","protected":false},"template":"","class_list":["post-2894","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"\nXPS\u2122 s\u00e5ld till Kina - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XPS\u2122 s\u00e5ld till Kina - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion har s\u00e5lt en XPS\u2122 till Kinas n\u00e4st st\u00f6rsta lungtransplantationsklinik, CHINA\u2013JAPAN FRIENDSHIP HOSPITAL, i Peking. P\u00e5 kliniken ska forskning...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sald-till-kina\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sald-till-kina\\\/\",\"name\":\"XPS\u2122 s\u00e5ld till Kina - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2019-09-18T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sald-till-kina\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sald-till-kina\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xps-sald-till-kina\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XPS\u2122 s\u00e5ld till Kina\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XPS\u2122 s\u00e5ld till Kina - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/","og_locale":"en_US","og_type":"article","og_title":"XPS\u2122 s\u00e5ld till Kina - XVIVO","og_description":"XVIVO Perfusion har s\u00e5lt en XPS\u2122 till Kinas n\u00e4st st\u00f6rsta lungtransplantationsklinik, CHINA\u2013JAPAN FRIENDSHIP HOSPITAL, i Peking. P\u00e5 kliniken ska forskning...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/","name":"XPS\u2122 s\u00e5ld till Kina - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2019-09-18T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xps-sald-till-kina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XPS\u2122 s\u00e5ld till Kina"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}